ETFs That Hold Halozyme Therapeutics (HALO)
Like Halozyme Therapeutics but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.
Reverse lookup across 662 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.
Common questions
How many ETFs hold Halozyme Therapeutics (HALO)?
Halozyme Therapeutics (HALO) is held by 212 US-listed ETFs, in each fund's latest reported holdings.
Which ETF holds the most Halozyme Therapeutics?
Of the US-listed ETFs in our fund data, The Future Fund Long/Short ETF (FFLS) holds Halozyme Therapeutics at the largest portfolio weight, in each fund's latest reported holdings.
What ETFs hold Halozyme Therapeutics?
By portfolio weight, the US-listed ETFs that hold the most Halozyme Therapeutics are FFLS, CSMD, SCAP, CANC and FBT, among others, in each fund's latest reported holdings.